Stanton Marshall S.'s Form 4/A amendment
AmendedArtivion, Inc. (AORT) · filed Mar 14, 2024
- Accession no.
- 0000784199-24-000144
- Filed
- Mar 14, 2024
- Trade date
- Feb 27, 2024
- Filing delay
- 16 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Feb 29, 2024
This filing lists 1 non-derivative transaction. Open-market sales total $9.22K. It was filed 16 days after the trade.
This amendment replaces 0000784199-24-000076 (filed Feb 29, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stanton Marshall S.CIK 0001849615 | Officer (SVP, Clinical & MD Affair) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Common Stock | SSaleDisposed | −465 | $19.83 | −$9,220.95 | 81,261 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
- F2
As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.